检索结果 - M. Lelgemann

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Intravitreal bevacizumab (Avastin) versus ranibizumab (Lucentis) for the treatment of age-related macular degeneration: a safety review

    Intravitreal bevacizumab (Avastin) versus ranibizumab (Lucentis) for the treatment of age-related macular degeneration: a safety review 由 Christine Schmucker, Yoon K. Loke, Christoph Ehlken, Hansjürgen Agostini, L. L. Hansen, Gerd Antes, M. Lelgemann

    出版 2010
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  2. 2
    Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials

    Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled t... 由 Dirk Eyding, M. Lelgemann, Ulrich Grouven, Martin Härter, Mandy Kromp, Thomas Kaiser, M Kerekeş, M Gerken, Beate Wieseler

    出版 2010
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:

检索工具: